Delivery Order SPE2DB20D9371-SPE2DB25FT1V3
Award Date 2/6/25
Potential Completion Date 2/7/25
Potential Value $2.2K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,436.40 contract covers the delivery of 4,567,133,666 units of Fexofenadine HCL 180 mg tablets to support the medical supply needs of military healthcare facilities. The contract is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,436.40 contract covers the delivery of 500 tablets of fexofenadine hydrochloride 180 mg to support the medical supply needs of military healthcare facilities. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business organization based in Park Ridge, Illinois. The contract is for the delivery of Fexofenadine Hydrochloride 180 mg tablets, with a potential value of $1,475.37 and a completion date of February 12, 2024. The contract has no set-aside designation. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDV) with the DLA, contract...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $2,872.80, is for the delivery of 4,567,372,728 units of Fexofenadine HCL 180 mg tablets by February 21, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract has a ceiling value of $1,436.40 and an ultimate completion date of February 10, 2025. The contract is for the supply of 4,567,248,727 units of Fexofenadine HCL 180 mg tablets, a pharmaceutical product. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois, is a delivery order valued at $2,460.12 issued by the Defense Logistics Agency (DLA). The contract is for the delivery of 4,567,324,784 tablets of the pharmaceutical drug Fexofenadine HCL 180 mg and has a completion date of January 31, 2025. The contract is not associated with any set-aside designation. It is part of a larger $499,999,999 Indefinite Delivery Contract (IDC)...
- This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The award is a delivery order valued at $1,903.78 for the provision of Fexofenadine HCL 180 mg tablets. The contract is a firm fixed-price delivery order that does not have a set-aside designation. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,407.38, is for the delivery of fexofenadine hydrochloride 180 mg tablets. The contract has a performance period through March 13, 2025 and is a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order valued at $1,057.95 to DMS Pharmaceutical Group Inc. for the supply of Fexofenadine HCL 180 mg tablets (500-count) on August 26, 2025, with an ultimate completion date of August 27, 2025. This firm fixed-price delivery order was issued without set-aside designation and will be performed in Park Ridge, Illinois, where the vendor is headquartered. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler that has...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order by the Defense Logistics Agency (DLA) for 500 tablets of Fexofenadine HCL 180 mg, with a ceiling value of $1,269.54. The award, issued on September 10, 2025, with an ultimate completion date of September 11, 2025, carries a firm fixed-price contract type with no set-aside designation. This delivery order is issued under DMS Pharmaceutical...